Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Oligoprogressive 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 29Fluorouracil 23Capecitabine 19pembrolizumab 17Nivolumab 17Leucovorin 16Docetaxel 10Paclitaxel 9Drug Therapy 9Cisplatin 9fludarabine 8Trastuzumab 8S 1 (combination) 8Cyclophosphamide 8Specimen Handling 7trastuzumab deruxtecan 6Bevacizumab 6Magnetic Resonance Spectroscopy 5Biopsy 5zolbetuximab 4Irinotecan 4Carboplatin 4zimberelimab 3sintilimab 3olaparib 3fludarabine phosphate 3durvalumab 3atezolizumab 3aldesleukin 3XELOX 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × DEAE-Dextran × 90 days × Clear all
NCT07607119 2026-05-28

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Samsung Medical Center

Phase NA Recruiting
53 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡